| Dr Corey Nathaniel Brown, DO | |
|
350 Crossgates Blvd, Brandon, MS 39042-2601 | |
| (662) 545-7300 | |
| Not Available |
| Full Name | Dr Corey Nathaniel Brown |
|---|---|
| Gender | Male |
| Speciality | Osteopathic Manipulative Medicine |
| Experience | 15 Years |
| Location | 350 Crossgates Blvd, Brandon, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487944617 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northwest Medical Center | Winfield, AL | Hospital |
| Greenwood Leflore Hospital | Greenwood, MS | Hospital |
| Wayne Medical Center | Waynesboro, TN | Hospital |
| Marion Regional Medical Center | Hamilton, AL | Hospital |
| Clay County Medical Corporation | West point, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Relias Emergency Medicine Specialists Of West Point, Llc | 0042648594 | 14 |
| Southeastern Emergency Physicians Llc | 2466364997 | 491 |
| Greenwood Leflore Hospital | 8123096880 | 5 |
| Southeastern Emergency Physicians Llc | 2466364997 | 491 |
| Nes Oklahoma, Inc. | 1456264324 | 69 |
News Archive
Researchers from the University of Bristol have discovered that a chemical compound in the brain can weaken the synaptic connections between neurons in a region of the brain important for the formation of long-term memories.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, and marketer of its branded, patented pterostilbene, pTeroPure, announced today a distribution agreement for pTeroPure with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company.
"The U.N. Entity for Gender Equality and the Empowerment of Women (U.N. Women) on Tuesday became the 11th member of the Joint U.N. Programme on HIV/AIDS (UNAIDS), a partnership that focuses on achieving universal access to HIV prevention, treatment, care and support," the U.N. News Centre reports.
In one of the first studies of its kind, researchers found that the prevalence of geriatric conditions and diabetic complications among older, insured patients with diabetes did not vary significantly by ethnicity.
› Verified 1 days ago
| Entity Name | North Mississippi Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972608347 PECOS PAC ID: 9931010600 Enrollment ID: O20040413000541 |
News Archive
Researchers from the University of Bristol have discovered that a chemical compound in the brain can weaken the synaptic connections between neurons in a region of the brain important for the formation of long-term memories.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, and marketer of its branded, patented pterostilbene, pTeroPure, announced today a distribution agreement for pTeroPure with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company.
"The U.N. Entity for Gender Equality and the Empowerment of Women (U.N. Women) on Tuesday became the 11th member of the Joint U.N. Programme on HIV/AIDS (UNAIDS), a partnership that focuses on achieving universal access to HIV prevention, treatment, care and support," the U.N. News Centre reports.
In one of the first studies of its kind, researchers found that the prevalence of geriatric conditions and diabetic complications among older, insured patients with diabetes did not vary significantly by ethnicity.
› Verified 1 days ago
| Entity Name | Webster Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982719621 PECOS PAC ID: 6901892421 Enrollment ID: O20040421001047 |
News Archive
Researchers from the University of Bristol have discovered that a chemical compound in the brain can weaken the synaptic connections between neurons in a region of the brain important for the formation of long-term memories.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, and marketer of its branded, patented pterostilbene, pTeroPure, announced today a distribution agreement for pTeroPure with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company.
"The U.N. Entity for Gender Equality and the Empowerment of Women (U.N. Women) on Tuesday became the 11th member of the Joint U.N. Programme on HIV/AIDS (UNAIDS), a partnership that focuses on achieving universal access to HIV prevention, treatment, care and support," the U.N. News Centre reports.
In one of the first studies of its kind, researchers found that the prevalence of geriatric conditions and diabetic complications among older, insured patients with diabetes did not vary significantly by ethnicity.
› Verified 1 days ago
| Entity Name | Pontotoc Health Services, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821103516 PECOS PAC ID: 6002895356 Enrollment ID: O20040719001336 |
News Archive
Researchers from the University of Bristol have discovered that a chemical compound in the brain can weaken the synaptic connections between neurons in a region of the brain important for the formation of long-term memories.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, and marketer of its branded, patented pterostilbene, pTeroPure, announced today a distribution agreement for pTeroPure with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company.
"The U.N. Entity for Gender Equality and the Empowerment of Women (U.N. Women) on Tuesday became the 11th member of the Joint U.N. Programme on HIV/AIDS (UNAIDS), a partnership that focuses on achieving universal access to HIV prevention, treatment, care and support," the U.N. News Centre reports.
In one of the first studies of its kind, researchers found that the prevalence of geriatric conditions and diabetic complications among older, insured patients with diabetes did not vary significantly by ethnicity.
› Verified 1 days ago
| Entity Name | Greenwood Leflore Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720048440 PECOS PAC ID: 8123096880 Enrollment ID: O20040921000072 |
News Archive
Researchers from the University of Bristol have discovered that a chemical compound in the brain can weaken the synaptic connections between neurons in a region of the brain important for the formation of long-term memories.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, and marketer of its branded, patented pterostilbene, pTeroPure, announced today a distribution agreement for pTeroPure with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company.
"The U.N. Entity for Gender Equality and the Empowerment of Women (U.N. Women) on Tuesday became the 11th member of the Joint U.N. Programme on HIV/AIDS (UNAIDS), a partnership that focuses on achieving universal access to HIV prevention, treatment, care and support," the U.N. News Centre reports.
In one of the first studies of its kind, researchers found that the prevalence of geriatric conditions and diabetic complications among older, insured patients with diabetes did not vary significantly by ethnicity.
› Verified 1 days ago
| Entity Name | Greenwood Leflore Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699714717 PECOS PAC ID: 1153399472 Enrollment ID: O20040923000500 |
News Archive
Researchers from the University of Bristol have discovered that a chemical compound in the brain can weaken the synaptic connections between neurons in a region of the brain important for the formation of long-term memories.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, and marketer of its branded, patented pterostilbene, pTeroPure, announced today a distribution agreement for pTeroPure with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company.
"The U.N. Entity for Gender Equality and the Empowerment of Women (U.N. Women) on Tuesday became the 11th member of the Joint U.N. Programme on HIV/AIDS (UNAIDS), a partnership that focuses on achieving universal access to HIV prevention, treatment, care and support," the U.N. News Centre reports.
In one of the first studies of its kind, researchers found that the prevalence of geriatric conditions and diabetic complications among older, insured patients with diabetes did not vary significantly by ethnicity.
› Verified 1 days ago
| Entity Name | Southeastern Emergency Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356379382 PECOS PAC ID: 2466364997 Enrollment ID: O20050407000866 |
News Archive
Researchers from the University of Bristol have discovered that a chemical compound in the brain can weaken the synaptic connections between neurons in a region of the brain important for the formation of long-term memories.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, and marketer of its branded, patented pterostilbene, pTeroPure, announced today a distribution agreement for pTeroPure with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company.
"The U.N. Entity for Gender Equality and the Empowerment of Women (U.N. Women) on Tuesday became the 11th member of the Joint U.N. Programme on HIV/AIDS (UNAIDS), a partnership that focuses on achieving universal access to HIV prevention, treatment, care and support," the U.N. News Centre reports.
In one of the first studies of its kind, researchers found that the prevalence of geriatric conditions and diabetic complications among older, insured patients with diabetes did not vary significantly by ethnicity.
› Verified 1 days ago
| Entity Name | United Emergency Services Of Mississippi |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801983309 PECOS PAC ID: 9739188046 Enrollment ID: O20061214000504 |
News Archive
Researchers from the University of Bristol have discovered that a chemical compound in the brain can weaken the synaptic connections between neurons in a region of the brain important for the formation of long-term memories.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, and marketer of its branded, patented pterostilbene, pTeroPure, announced today a distribution agreement for pTeroPure with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company.
"The U.N. Entity for Gender Equality and the Empowerment of Women (U.N. Women) on Tuesday became the 11th member of the Joint U.N. Programme on HIV/AIDS (UNAIDS), a partnership that focuses on achieving universal access to HIV prevention, treatment, care and support," the U.N. News Centre reports.
In one of the first studies of its kind, researchers found that the prevalence of geriatric conditions and diabetic complications among older, insured patients with diabetes did not vary significantly by ethnicity.
› Verified 1 days ago
| Entity Name | Shaw Family Medical, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750642633 PECOS PAC ID: 3072769843 Enrollment ID: O20120809000742 |
News Archive
Researchers from the University of Bristol have discovered that a chemical compound in the brain can weaken the synaptic connections between neurons in a region of the brain important for the formation of long-term memories.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, and marketer of its branded, patented pterostilbene, pTeroPure, announced today a distribution agreement for pTeroPure with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company.
"The U.N. Entity for Gender Equality and the Empowerment of Women (U.N. Women) on Tuesday became the 11th member of the Joint U.N. Programme on HIV/AIDS (UNAIDS), a partnership that focuses on achieving universal access to HIV prevention, treatment, care and support," the U.N. News Centre reports.
In one of the first studies of its kind, researchers found that the prevalence of geriatric conditions and diabetic complications among older, insured patients with diabetes did not vary significantly by ethnicity.
› Verified 1 days ago
| Entity Name | Mississippi Emergency Physician Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710220678 PECOS PAC ID: 2264672492 Enrollment ID: O20130710000827 |
News Archive
Researchers from the University of Bristol have discovered that a chemical compound in the brain can weaken the synaptic connections between neurons in a region of the brain important for the formation of long-term memories.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, and marketer of its branded, patented pterostilbene, pTeroPure, announced today a distribution agreement for pTeroPure with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company.
"The U.N. Entity for Gender Equality and the Empowerment of Women (U.N. Women) on Tuesday became the 11th member of the Joint U.N. Programme on HIV/AIDS (UNAIDS), a partnership that focuses on achieving universal access to HIV prevention, treatment, care and support," the U.N. News Centre reports.
In one of the first studies of its kind, researchers found that the prevalence of geriatric conditions and diabetic complications among older, insured patients with diabetes did not vary significantly by ethnicity.
› Verified 1 days ago
| Entity Name | Correct Care, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215987441 PECOS PAC ID: 8628980992 Enrollment ID: O20131122000662 |
News Archive
Researchers from the University of Bristol have discovered that a chemical compound in the brain can weaken the synaptic connections between neurons in a region of the brain important for the formation of long-term memories.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, and marketer of its branded, patented pterostilbene, pTeroPure, announced today a distribution agreement for pTeroPure with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company.
"The U.N. Entity for Gender Equality and the Empowerment of Women (U.N. Women) on Tuesday became the 11th member of the Joint U.N. Programme on HIV/AIDS (UNAIDS), a partnership that focuses on achieving universal access to HIV prevention, treatment, care and support," the U.N. News Centre reports.
In one of the first studies of its kind, researchers found that the prevalence of geriatric conditions and diabetic complications among older, insured patients with diabetes did not vary significantly by ethnicity.
› Verified 1 days ago
| Entity Name | Relias Emergency Medicine Specialists Of Tupelo Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841664661 PECOS PAC ID: 6608179734 Enrollment ID: O20160125001174 |
News Archive
Researchers from the University of Bristol have discovered that a chemical compound in the brain can weaken the synaptic connections between neurons in a region of the brain important for the formation of long-term memories.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, and marketer of its branded, patented pterostilbene, pTeroPure, announced today a distribution agreement for pTeroPure with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company.
"The U.N. Entity for Gender Equality and the Empowerment of Women (U.N. Women) on Tuesday became the 11th member of the Joint U.N. Programme on HIV/AIDS (UNAIDS), a partnership that focuses on achieving universal access to HIV prevention, treatment, care and support," the U.N. News Centre reports.
In one of the first studies of its kind, researchers found that the prevalence of geriatric conditions and diabetic complications among older, insured patients with diabetes did not vary significantly by ethnicity.
› Verified 1 days ago
| Entity Name | Carr, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548677610 PECOS PAC ID: 1850512153 Enrollment ID: O20160707000686 |
News Archive
Researchers from the University of Bristol have discovered that a chemical compound in the brain can weaken the synaptic connections between neurons in a region of the brain important for the formation of long-term memories.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, and marketer of its branded, patented pterostilbene, pTeroPure, announced today a distribution agreement for pTeroPure with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company.
"The U.N. Entity for Gender Equality and the Empowerment of Women (U.N. Women) on Tuesday became the 11th member of the Joint U.N. Programme on HIV/AIDS (UNAIDS), a partnership that focuses on achieving universal access to HIV prevention, treatment, care and support," the U.N. News Centre reports.
In one of the first studies of its kind, researchers found that the prevalence of geriatric conditions and diabetic complications among older, insured patients with diabetes did not vary significantly by ethnicity.
› Verified 1 days ago
| Entity Name | App Of Mississippi Ed Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730687740 PECOS PAC ID: 3971865858 Enrollment ID: O20180313002534 |
News Archive
Researchers from the University of Bristol have discovered that a chemical compound in the brain can weaken the synaptic connections between neurons in a region of the brain important for the formation of long-term memories.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, and marketer of its branded, patented pterostilbene, pTeroPure, announced today a distribution agreement for pTeroPure with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company.
"The U.N. Entity for Gender Equality and the Empowerment of Women (U.N. Women) on Tuesday became the 11th member of the Joint U.N. Programme on HIV/AIDS (UNAIDS), a partnership that focuses on achieving universal access to HIV prevention, treatment, care and support," the U.N. News Centre reports.
In one of the first studies of its kind, researchers found that the prevalence of geriatric conditions and diabetic complications among older, insured patients with diabetes did not vary significantly by ethnicity.
› Verified 1 days ago
| Entity Name | Erx Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760823082 PECOS PAC ID: 9335037571 Enrollment ID: O20190118000946 |
News Archive
Researchers from the University of Bristol have discovered that a chemical compound in the brain can weaken the synaptic connections between neurons in a region of the brain important for the formation of long-term memories.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, and marketer of its branded, patented pterostilbene, pTeroPure, announced today a distribution agreement for pTeroPure with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company.
"The U.N. Entity for Gender Equality and the Empowerment of Women (U.N. Women) on Tuesday became the 11th member of the Joint U.N. Programme on HIV/AIDS (UNAIDS), a partnership that focuses on achieving universal access to HIV prevention, treatment, care and support," the U.N. News Centre reports.
In one of the first studies of its kind, researchers found that the prevalence of geriatric conditions and diabetic complications among older, insured patients with diabetes did not vary significantly by ethnicity.
› Verified 1 days ago
| Entity Name | Grenada Physician Services, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932762721 PECOS PAC ID: 4284965773 Enrollment ID: O20191015001194 |
News Archive
Researchers from the University of Bristol have discovered that a chemical compound in the brain can weaken the synaptic connections between neurons in a region of the brain important for the formation of long-term memories.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, and marketer of its branded, patented pterostilbene, pTeroPure, announced today a distribution agreement for pTeroPure with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company.
"The U.N. Entity for Gender Equality and the Empowerment of Women (U.N. Women) on Tuesday became the 11th member of the Joint U.N. Programme on HIV/AIDS (UNAIDS), a partnership that focuses on achieving universal access to HIV prevention, treatment, care and support," the U.N. News Centre reports.
In one of the first studies of its kind, researchers found that the prevalence of geriatric conditions and diabetic complications among older, insured patients with diabetes did not vary significantly by ethnicity.
› Verified 1 days ago
| Entity Name | Relias Emergency Medicine Specialists Of Amory, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265074769 PECOS PAC ID: 4486088853 Enrollment ID: O20191218002639 |
News Archive
Researchers from the University of Bristol have discovered that a chemical compound in the brain can weaken the synaptic connections between neurons in a region of the brain important for the formation of long-term memories.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, and marketer of its branded, patented pterostilbene, pTeroPure, announced today a distribution agreement for pTeroPure with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company.
"The U.N. Entity for Gender Equality and the Empowerment of Women (U.N. Women) on Tuesday became the 11th member of the Joint U.N. Programme on HIV/AIDS (UNAIDS), a partnership that focuses on achieving universal access to HIV prevention, treatment, care and support," the U.N. News Centre reports.
In one of the first studies of its kind, researchers found that the prevalence of geriatric conditions and diabetic complications among older, insured patients with diabetes did not vary significantly by ethnicity.
› Verified 1 days ago
| Entity Name | Relias Hospitalist Medicine Specialists Of Amory Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205470796 PECOS PAC ID: 0143656165 Enrollment ID: O20200210002414 |
News Archive
Researchers from the University of Bristol have discovered that a chemical compound in the brain can weaken the synaptic connections between neurons in a region of the brain important for the formation of long-term memories.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, and marketer of its branded, patented pterostilbene, pTeroPure, announced today a distribution agreement for pTeroPure with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company.
"The U.N. Entity for Gender Equality and the Empowerment of Women (U.N. Women) on Tuesday became the 11th member of the Joint U.N. Programme on HIV/AIDS (UNAIDS), a partnership that focuses on achieving universal access to HIV prevention, treatment, care and support," the U.N. News Centre reports.
In one of the first studies of its kind, researchers found that the prevalence of geriatric conditions and diabetic complications among older, insured patients with diabetes did not vary significantly by ethnicity.
› Verified 1 days ago
| Entity Name | Relias Hospitalist Medicine Specialists Of West Point Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821638578 PECOS PAC ID: 4688002322 Enrollment ID: O20200312000355 |
News Archive
Researchers from the University of Bristol have discovered that a chemical compound in the brain can weaken the synaptic connections between neurons in a region of the brain important for the formation of long-term memories.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, and marketer of its branded, patented pterostilbene, pTeroPure, announced today a distribution agreement for pTeroPure with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company.
"The U.N. Entity for Gender Equality and the Empowerment of Women (U.N. Women) on Tuesday became the 11th member of the Joint U.N. Programme on HIV/AIDS (UNAIDS), a partnership that focuses on achieving universal access to HIV prevention, treatment, care and support," the U.N. News Centre reports.
In one of the first studies of its kind, researchers found that the prevalence of geriatric conditions and diabetic complications among older, insured patients with diabetes did not vary significantly by ethnicity.
› Verified 1 days ago
| Entity Name | Relias Emergency Medicine Specialists Of West Point, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275172736 PECOS PAC ID: 0042648594 Enrollment ID: O20200316000656 |
News Archive
Researchers from the University of Bristol have discovered that a chemical compound in the brain can weaken the synaptic connections between neurons in a region of the brain important for the formation of long-term memories.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, and marketer of its branded, patented pterostilbene, pTeroPure, announced today a distribution agreement for pTeroPure with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company.
"The U.N. Entity for Gender Equality and the Empowerment of Women (U.N. Women) on Tuesday became the 11th member of the Joint U.N. Programme on HIV/AIDS (UNAIDS), a partnership that focuses on achieving universal access to HIV prevention, treatment, care and support," the U.N. News Centre reports.
In one of the first studies of its kind, researchers found that the prevalence of geriatric conditions and diabetic complications among older, insured patients with diabetes did not vary significantly by ethnicity.
› Verified 1 days ago
| Entity Name | Glutality Provider Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083256168 PECOS PAC ID: 9032549837 Enrollment ID: O20200909001506 |
News Archive
Researchers from the University of Bristol have discovered that a chemical compound in the brain can weaken the synaptic connections between neurons in a region of the brain important for the formation of long-term memories.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, and marketer of its branded, patented pterostilbene, pTeroPure, announced today a distribution agreement for pTeroPure with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company.
"The U.N. Entity for Gender Equality and the Empowerment of Women (U.N. Women) on Tuesday became the 11th member of the Joint U.N. Programme on HIV/AIDS (UNAIDS), a partnership that focuses on achieving universal access to HIV prevention, treatment, care and support," the U.N. News Centre reports.
In one of the first studies of its kind, researchers found that the prevalence of geriatric conditions and diabetic complications among older, insured patients with diabetes did not vary significantly by ethnicity.
› Verified 1 days ago
| Entity Name | Delta Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215501788 PECOS PAC ID: 5890101208 Enrollment ID: O20210603000314 |
News Archive
Researchers from the University of Bristol have discovered that a chemical compound in the brain can weaken the synaptic connections between neurons in a region of the brain important for the formation of long-term memories.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, and marketer of its branded, patented pterostilbene, pTeroPure, announced today a distribution agreement for pTeroPure with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company.
"The U.N. Entity for Gender Equality and the Empowerment of Women (U.N. Women) on Tuesday became the 11th member of the Joint U.N. Programme on HIV/AIDS (UNAIDS), a partnership that focuses on achieving universal access to HIV prevention, treatment, care and support," the U.N. News Centre reports.
In one of the first studies of its kind, researchers found that the prevalence of geriatric conditions and diabetic complications among older, insured patients with diabetes did not vary significantly by ethnicity.
› Verified 1 days ago
| Entity Name | Delta Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053086819 PECOS PAC ID: 1850778689 Enrollment ID: O20220517003246 |
News Archive
Researchers from the University of Bristol have discovered that a chemical compound in the brain can weaken the synaptic connections between neurons in a region of the brain important for the formation of long-term memories.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, and marketer of its branded, patented pterostilbene, pTeroPure, announced today a distribution agreement for pTeroPure with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company.
"The U.N. Entity for Gender Equality and the Empowerment of Women (U.N. Women) on Tuesday became the 11th member of the Joint U.N. Programme on HIV/AIDS (UNAIDS), a partnership that focuses on achieving universal access to HIV prevention, treatment, care and support," the U.N. News Centre reports.
In one of the first studies of its kind, researchers found that the prevalence of geriatric conditions and diabetic complications among older, insured patients with diabetes did not vary significantly by ethnicity.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Corey Nathaniel Brown, DO Po Box 599, Flora, MS 39071-0599 Ph: (662) 545-7300 | Dr Corey Nathaniel Brown, DO 350 Crossgates Blvd, Brandon, MS 39042-2601 Ph: (662) 545-7300 |
News Archive
Researchers from the University of Bristol have discovered that a chemical compound in the brain can weaken the synaptic connections between neurons in a region of the brain important for the formation of long-term memories.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, and marketer of its branded, patented pterostilbene, pTeroPure, announced today a distribution agreement for pTeroPure with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company.
"The U.N. Entity for Gender Equality and the Empowerment of Women (U.N. Women) on Tuesday became the 11th member of the Joint U.N. Programme on HIV/AIDS (UNAIDS), a partnership that focuses on achieving universal access to HIV prevention, treatment, care and support," the U.N. News Centre reports.
In one of the first studies of its kind, researchers found that the prevalence of geriatric conditions and diabetic complications among older, insured patients with diabetes did not vary significantly by ethnicity.
› Verified 1 days ago
George B Schimmel, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 346 Crossgates Blvd, Suite 203, Brandon, MS 39042 Phone: 601-825-2424 Fax: 601-825-7621 | |
Dr. Lloyd James Gordon Iii, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 3949 Highway 43 N, Brandon, MS 39047 Phone: 601-829-2500 | |
Dominic Arthur Jaeger, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 350 Crossgates Blvd, Brandon, MS 39042 Phone: 601-664-1361 | |
Dr. Shuja Yousuf, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 348 Crossgates Blvd Ste 1300, Brandon, MS 39042 Phone: 601-825-5000 | |
Nusrat J Khansur, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1551 W Government St, Brandon, MS 39042 Phone: 601-825-3163 Fax: 601-825-7893 |